AMD Research Update — September 19, 2026 (Updated)
Updated Thesis
Advanced Micro Devices designs x86 CPUs, GPUs, and data-center accelerators across two segments, Computing and Graphics and Enterprise, Embedded and Semi-Custom, with 31,000 employees and a $1.002 trillion market capitalization at $614.61 per share. The business quality is genuinely improving: revenue grew 50.1% year over year in the most recent quarter, earnings grew 163.4% year over year in the most recent quarter, and TTM gross margin is 53.2%, but TTM operating margin of 15.7%, TTM net margin of 15.6%, and ROE of 10.1% remain modest for a company priced at 24.26 times sales, 155.8 times trailing earnings, 119.29 times free cash flow, and 93.43 times EV/EBITDA. The stock is very expensive relative to its own five-year history, and our blended fair value estimate of $530.25 implies 13.7% downside to fair value, a 15.9% premium to fair value, even though the analyst consensus is Strong Buy with a $650.33 average target, only 5.8% above the current price.
The investment grade as of this refresh is C — average business quality. B-tier business, D-tier valuation with 13.7% downside to $530.25 fair value.
Key Metrics at a Glance
- Revenue growth: +50.1% year over year
- Net margin: 15.6%
- Fair value upside: -13.7% to our estimate of $530
Current price: $614.61
These figures reflect our most recent data pull and are one input into a multi-factor valuation framework.
Our 12–18 Month Outlook
Quality companies held over a multi-year horizon benefit from compounding fundamentals and the patience to ride through short-term volatility. Advanced Micro Devices, Inc. remains in our covered universe with a average-quality assessment. We update research when material data changes — earnings revisions, management shifts, or regime changes in valuation — not on every price fluctuation.
Long-term accumulation of quality businesses at fair or better prices is the core of the Patient Accumulator approach. Research updates like this one inform whether to add, hold, or wait for a better zone — not whether to react to short-term price moves.
[View full AMD research →](/stocks/AMD)